Determination of free malondialdehyde in human serum by high-performance liquid chroma tography

Analytical Biochemistry

Volumn 311, Issue 1, 2002, Pages 76-79

  Karatas, F ^a   Karatepe, M ^a   Baysar, A ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Goiter; HPLC; MDA; Serum

Indexed keywords

DETERIORATION; LIPIDS; OXIDATION; POLYUNSATURATED FATTY ACIDS;

CLINICAL MEASUREMENTS; DETECTION LIMITS; GOITER; HPLC; LIPID PEROXIDATION; MALONDIALDEHYDE; SENSITIVE METHOD; SERUM;

ALDEHYDES;

MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; THYROID HORMONE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; GOITER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTHYROIDISM; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MEASUREMENT; PATHOGENESIS; PH; PRIORITY JOURNAL; SERUM; TISSUE INJURY; BLOOD; CALIBRATION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GOITER; HUMANS; MALONDIALDEHYDE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036901664     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00387-1     Document Type: Article

References (16)

1. J. Templar, S.P. Kon, T.P. Milligan, D.J. Newman, M.J. Raftery, Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method, Nephrol. Dial. Transplant. 14 (4) (1999) 946-951.
2. T. Ozben, S. Nacitarhan, N. Tuncer, Plasma and urine malondialdehyde levels in non-insulin dependent diabetic patients with and without microalbuminuria, Int. J. Clin. Lab. Res. 25 (1995) 162-164.
3. B. Halliwell, Free radicals and vascular disease: How much do we know?, Br. Med. J. 307 (1993) 885.
4. P.A. Cerutti, Oxy. Radicals and cancer, Lancet 344 (1994) 862-863.
5. M.E. Gotz, A. Freyberger, P. Riederer, Oxidative stress - A role in the pathogenesis of Parkinson's disease, J. Neural. Transm. S 29 (1990) 241-249.
6. A.J. Drury, J.A. Nycyk, W.I.C. Richard, Comparison of urinary and plasma malondialdehyde in preterm infants, Clin. Chim. Acta 263 (1997) 177-185.
7. L. Dimitriu, R. Bartoc, H. Ursu, V. Ionescu, Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper-and hypothyroidsm, Endocrinology 26 (1988) 35-38.
8. L.A. Videla, T. Sir, C. Wolff, Increased lipid peroxidation in hyperthyroid patients: Suppression by propylthiouracil treatment, Free Radicals Res. Commun. 5 (1988) 1-10.
9. K. Asayama, K. Kato, Oxidative muscular injury and its relevance to hyperthyroidism, Free Radicals Biol. Med. 8 (1990) 293-303.
10. T. Saito, Superoxide dismutase level in human erytrocytes and its clinical application to the patients with cancers and thyroidal functions, Hokkaido Igaku Zasshi 62 (1987) 257-268.
11. H. Esterbauer, R.J. Schaur, H. Zollner, Chemistry and biochemistry of 4-hydroxynoneal malondialdehyde and related aldehydes, Free Radicals Biol. Med. 11 (1991) 81-128.
12. J. Tsaknis, L. Stavros, H. Michael, S. Gillian, T. Vassiliki, Rapid high performance liquid chromatographic method of determining malondialdehyde for evaluation of rancidity in edible oils, Analyst 123 (1998) 325-327.
13. J. Steghens, A.L. van Kappel, I. Denis, C. Collombel, Diaminonaphtalane, a new highly specific regent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum, Free Radicals Biol. Med. 31 (2001) 242-249.
14. J.A. Knight, R.K. Pieper, L. McClellan, Specifity of the thiobarbituric acid reaction: Its use in studies of lipid peroxidation, Clin. Chem. 34 (1988) 2433-2438.
15. H.H. Draper, E.J. Squires, H. Mahmoodi, J. Wu, S. Agarwal, M. Hadley, A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials, Free Radicals Biol. Med. 15 (1993) 353-363.
16. M. Hultqvist, J. Hegbrant, C.T. Nilson, T. Lindholm, P. Nilson, T. Linden, B.U. Hultqvist, Plasma concentrations of vitamin C, vitamin E, and/or malondialdehyde as markers of oxygen free radical production during hemodialysis, Clin. Nephrol. 47 (1997) 37-46.